Evidence map›Paper›PMID 32329713›Full record

ArticleeLife2020

Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation.

Tim Dd Somerville, Giulia Biffi, Juliane Daßler-Plenker, Stella K Hur, Xue-Yan He, Krysten E Vance, Koji Miyabayashi, Yali Xu, Diogo Maia-Silva, Olaf Klingbeil and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. [Research progress in clinical pathology and molecular mechanisms of pancreatic adenosquamous carcinoma].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Review
  5. The Significance of CXCL1 in Cancer: An Overview of Molecular Mechanisms.International journal of molecular sciences · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4Journal of experimental & clinical cancer research : CR · 2025
    Article
  18. Article
  19. Article
  20. Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer.Thyroid : official journal of the American Thyroid Association · 2024
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Tim Dd SomervilleCold Spring Harbor Laboratory, Cold Spring Harbor, United States.ORCID 0000-0002-6295-6126
Giulia BiffiCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Juliane Daßler-PlenkerCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Stella K HurCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Xue-Yan HeCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Krysten E VanceEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.
Koji MiyabayashiCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Yali XuCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Diogo Maia-SilvaCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Olaf KlingbeilCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Osama E DemerdashCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Jonathan B PreallCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Michael A HollingsworthEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.
Mikala EgebladCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
David A TuvesonCold Spring Harbor Laboratory, Cold Spring Harbor, United States.
Christopher R VakocCold Spring Harbor Laboratory, Cold Spring Harbor, United States.ORCID 0000-0002-1158-7180
Cold Spring Harbor Laboratory · USUniversity of Nebraska Medical Center · USUniversity of Cambridge · GB

Funding

Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI John Edward Moses · 1987 to 2026
$118.9M
VIRAL TRANSACTIVATIONP01CA013106 · NCI · COLD SPRING HARBOR LABORATORY · PI William Richard McCombie · 1985 to 2026
$116.8M
REGULATION OF DNA REPLICATIONR01GM045436 · NIGMS · COLD SPRING HARBOR LABORATORY · PI STILLMAN, BRUCE W. · 1991 to 2025
$15.8M
Pancreatic Cancer Detection ConsortiumU01CA210240 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Michael A. Hollingsworth · 2017 to 2026
$12.9M
UAB / UMN SPORE in Pancreatic CancerP50CA101955 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BUCHSBAUM, DONALD J · 2010 to 2014
$11.1M
CHEMICAL CARCINOGENESIS &CANCER BIOLOGYT32CA009476 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer D. Black · 1988 to 2026
$6.2M
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor HeterogeneityU01CA224013 · NCI · COLD SPRING HARBOR LABORATORY · PI ROBSON, PAUL, TUVESON, DAVID A · 2018 to 2022
$4.2M
Targeting aberrant enhancer landscapes in pancreatic cancerR01CA229699 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Christopher Vakoc · 2019 to 2026
$3.3M
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment ResponseR01CA188134 · NCI · COLD SPRING HARBOR LABORATORY · PI TUVESON, DAVID A · 2017 to 2021
$3.0M
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic CancerR01CA190092 · NCI · COLD SPRING HARBOR LABORATORY · PI TUVESON, DAVID A · 2014 to 2017
$2.2M
Integrated Translational Cancer Science CenterU10CA180944 · NCI · COLD SPRING HARBOR LABORATORY · PI BAKER, LAURENCE HOWARD, LIU, EDISON TAK-BUN · 2014 to 2018
$2.0M
Training and Education ProgramP20CA192994 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI LI, ELLEN · 2015 to 2018
$1.6M
NCI NIH HHS 1R01CA190092NCI NIH HHS 5P01CA013106-Project 4NCI NIH HHS 5P50CA101955NCI NIH HHS P01 CA013106NCI NIH HHS P20 CA192994NCI NIH HHS P20 CA192996NCI NIH HHS P30 CA045508NCI NIH HHS P50 CA101955NCI NIH HHS R01 CA188134NCI NIH HHS R01 CA190092NCI NIH HHS R01 CA229699NCI NIH HHS T32 CA009476NCI NIH HHS U01 CA210240NCI NIH HHS U01 CA224013NCI NIH HHS U10 CA180944NCI NIH HHS U10CA180944Pancreatic Cancer Action Network 16-20-25-VAKO
6 · The paper itself

Abstract

A highly aggressive subset of pancreatic ductal adenocarcinomas undergo trans-differentiation into the squamous lineage during disease progression. Here, we investigated whether squamous trans-differentiation of human and mouse pancreatic cancer cells can influence the phenotype of non-neoplastic cells in the tumor microenvironment. Conditioned media experiments revealed that squamous pancreatic cancer cells secrete factors that recruit neutrophils and convert pancreatic stellate cells into cancer-associated fibroblasts (CAFs) that express inflammatory cytokines at high levels. We use gain- and loss-of-function approaches to show that squamous-subtype pancreatic tumor models become enriched with neutrophils and inflammatory CAFs in a p63-dependent manner. These effects occur, at least in part, through p63-mediated activation of enhancers at pro-inflammatory cytokine loci, which includes

Indexed as

AnimalsCancer-Associated FibroblastsCarcinoma, Pancreatic DuctalCell LineageCell TransdifferentiationCytokinesHumansInflammationMembrane ProteinsMiceMice, Inbred C57BLNeutrophil InfiltrationPancreatic NeoplasmsStromal CellsTumor MicroenvironmentCKAP4 protein, humanCytokinesMembrane Proteinscancer-associated fibroblastscancer biologyhumanhuman biologyinflammationmedicinemousepancreatic cancersquamousTP63trans-differentiation

Identifiers

PMID32329713
PMCPMC7200154
OpenAlexW3020400196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.